Skip to content

Drug interactions

Darolutamide + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Moderate

Darolutamide and Sofosbuvir-velpatasvir-voxilaprevir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Darolutamide inhibits BCRP and P-gp, which handle velpatasvir, voxilaprevir and sofosbuvir. Exposure to the HCV drugs may rise. The clinical effect is likely modest but has been flagged in labeling.

What this interaction means in plain words

Darolutamide and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Darolutamide belongs to Miscellaneous; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

Darolutamide inhibits BCRP and P-gp efflux, which increases HCV drug absorption.

What to do

Monitor for adverse effects of the HCV regimen such as headache and fatigue, or consider an alternative if tolerability is poor.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darolutamide and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darolutamide with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as moderate. Darolutamide and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Darolutamide inhibits BCRP and P-gp, which handle velpatasvir, voxilaprevir and sofosbuvir. Exposure to the HCV drugs may rise. The clinical effect is likely modest but has been flagged in labeling.

How serious is the interaction between Darolutamide and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for adverse effects of the HCV regimen such as headache and fatigue, or consider an alternative if tolerability is poor.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in